Regulation of mTOR by phosphatidic acid?

Cancer Research

Volumn 67, Issue 1, 2007, Pages 1-4

  Foster, David A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FK 506 BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; RAPAMYCIN;

CELL STRAIN HEK293; CELL STRAIN MCF 7; CELL SURVIVAL; DRUG ACTIVITY; DRUG BINDING; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; PROTEIN KINASES;

EID: 33846438568     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3016     Document Type: Review

References (26)

1. Sarbassov DD, Ali SM. Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005;17:596-603.
2. Tee AR, Blenis J. mTOR, Lranslational control and human disease. Semin Cell Dev Biol 2005;16:29-37.
3. Fang Y, Vilella-Baeh M, Bachmann R, et al. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001;294:1942-5.
4. Exton JH. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol 2002;144:1-94.
5. Foster DA. Phospholipase D survival signals as a therapeutic target in cancer. Curr Signal Transduction Ther 2006;1:295-303.
6. Chen J, Fang Y. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. Biochem Pharmacol 2002;64:1071-7.
7. Chen Y, Zheng Y, Foster DA. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 2003;22:3937-42.
8. Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J Biol Chem 2002;277:31423-9.
9. Tee AR, Anjum R, Blenis J. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J Biol Chem 2003;278:37288-96.
10. Lim HK, Choi YA, Park W, et al. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 2003;278:45117-27.
11. Xu Y, Fang Y, Chen J, Prestwich GD. Activation of mTOR signaling by novel fluoromethylene phosphonate analogues of phosphatidic acid. Bioorg Med Chem Lett 2004;14:1461-4.
12. Ballon LM, Jiang YP, Du G, Frohman MA, Lin RZ. Ca(2+)- and phospholipase D-dependent and -independent pathways activate mTOR signaling. FEBS Lett 2003;550:51-6.
13. Hornberger TA, Chu WK, Mak YW, Hsiung JVV, Huang SA, Chien S. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci U S A 2006;103:4741-6.
14. Takahara T, Hara K, Yonezawa K, Sorimachi H, Maeda T. Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region. J Biol Chem 2006;281:28605-14.
15. Chen Y, Rodrik V, Foster DA. Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene 2005;24:672-9.
16. Hui L, Abbas T, Pielak R, Joseph T, Bargonetti J, Foster DA. Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mol Cell Biol 2004;24:5677-88.
17. Kam Y, Exton JH. Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid. FASEB J 2004;18:311-9.
18. Fang Y, Park IH, Wu AL, et al. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr Biol 2003;13:2037-44.
19. Ohguchi K, Banno Y, Nakagawa Y, Akao Y, Nozawa V. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells. J Cell Physiol 2005;205:444-51.
20. Hui L, Rodrik V, Pielak RM, Zheng Y, Foster DA. mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells. J Biol Chem 2005;280:35829-35.
21. Ha SH, Kim DH, Kim IS, et al. PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. Cell Signal 2006;18:2283-91. Epub 2006 Jun 3.
22. Coon M, Ball A, Pound J, et al. Inhibition of lysophosphatidic acid acyltransferase-β disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. Mol Cancer Ther 2003;2:1067-78.
23. Avila-Flores A, Santos T, Rincon E, Merida I. Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid. J Biol Chem 2005;280:10091-9.
24. Zheng Y, Rodrik V, Toschi A, et al. Phospholipase D couples survival and migration signals in response to stress in human breast cancer cells. J Biol Chem 2006;281:15862-8.
25. Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 2006;6:729-34.
26. Sarbassov DD, Ali SM, Kim DH, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004;14:1296-302.